for Sep 17, 2020
1/ “Heavy exposure of children aged 9 to 12 years with SARS-CoV-2 did not lead to infection” Journal of the Pediatric Infectious Diseases Society, September 12, 2020 https://t.co/r7Fm7eq5UX
— Andrew Bostom (@andrewbostom) September 17, 2020
People who volunteer for ethically done, scientifically sound clinical research studies are some of our society's unsung heroes. Well done, @MollyJongFast. 👏👏👏
— Paul Sax (@PaulSaxMD) September 17, 2020
I Am the Joan of Arc of Coronavirus Vaccine Trials https://t.co/dQWhtZuvTo
1. Dr. Scott Atlas, a radiologist with no background in public health, epidemiology or infectious diseases who joined President Trump’s coronavirus response, hired attorney Marc Kasowitz to intimidate a group of Stanford doctors and researchers.https://t.co/NYdVK2YW2w
— The Intellectualist (@highbrow_nobrow) September 17, 2020
🔥🔥Very interesting🔥🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 17, 2020
Challenging ‘dogma’ Cefazolin in MSSA IE
Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in MSSA infective endocarditis: a post-hoc analysis of a prospective multicentre French cohort study. #IDTwitter https://t.co/Yjvt813SrK pic.twitter.com/9dWUdatJLs
The AAAAI joined the IDSA requesting the Centers for Medicare and Medicaid Services (CMS) require that U.S. hospitals include verification of penicillin allergy as part of mandatory antibiotic stewardship programs (ASPs). https://t.co/IQzQRGj70T
— Eric Macy (@EricMacyMD) September 17, 2020
Cefiderocol as rescue therapy for Acinetobacter baumannii & other carbapenem resistant Gram-Negative infections in ICU patients. #IDTwitter #CID https://t.co/W5z8PA0nhg
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 17, 2020
one positive side effect among the many negative ones of lockdown & social distancing & masks etc is that what works for COVID also works for other infectious respiratory diseases... like flu! https://t.co/FElSLmzne6
— Christina Pagel (@chrischirp) September 17, 2020
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors | @AnnalsofIM https://t.co/6g2yoQGWQA. Fantastic paper by @PaulSaxMD @RMKGandhi and colleagues summarizing the state of knowledge of #SARSCoV2 transmission. A “must read”.
— Carlos del Rio (@CarlosdelRio7) September 17, 2020
Great study of nosocomial #COVID19 in a hospital with (VERY) robust infection prevention measures: there was only 1 nosocomial case across 9,149 admitted patients over a 12 week period (!!) 🔥
— Mike Stevens (@Dr_Mike_Stevens) September 17, 2020
Need to keep focused on/investing in infection prevention!!!https://t.co/BdcVlN01mx pic.twitter.com/kDbK1aneYU
👏 UAB receives IDSA Antimicrobial Stewardship Centers of Excellence Designation https://t.co/yWTAlkqzMf pic.twitter.com/2WJhEjwliT
— UAB Medicine (@uabmedicine) September 17, 2020
Congratulations, Dr. Margaret Taylor for receiving the Antimicrobial Stewardship Fellowship Award from @PIDSociety for a dual-center review of #penicillin #allergy #labels in #Children under the mentorship of Dr. Debra Palazzi: https://t.co/Mtm4XMWuKb pic.twitter.com/1pr5oDdhOW
— TCHResearchNews (@TCHResearchNews) September 17, 2020
Interesting - a new method for combating antibiotic resistance in microbes https://t.co/Q4DtuQmQsq
— BSAC (@BSACandJAC) September 17, 2020
One more reason to delabel.
— Eric Macy (@EricMacyMD) September 17, 2020
Preoperative Allergy Testing for Patients Reporting Penicillin and Cephalosporin Allergies is Cost-Effective in Preventing Infection after Total Knee and Hip Arthroplasty https://t.co/tg5Tj3LLw5
New research Article: Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial https://t.co/8zhRR1xIe2 #phage #UTI
— The Lancet Infectious Diseases (@TheLancetInfDis) September 17, 2020
.@CDCgov #Coronavirus Testing Guidance Posted Against Scientists’ Objections - @nytimes by @apoorva_nyc not sure which quote is best @DrTomFrieden “vandalizing a national monument with graffiti” or me talking about clearance https://t.co/cuIfVCC7yX
— Carlos del Rio (@CarlosdelRio7) September 17, 2020
A new study in @mSphereJ analyzes the association between insertion sequences and antibiotic resistance genes. https://t.co/LreRo7IJqk pic.twitter.com/rcTQGE9V2v
— ASM (@ASMicrobiology) September 17, 2020
Antibiotics are the weakest link in our health and economic security and their discovery and access needs government investment and partnership. #AntimcrobialResistancehttps://t.co/lZSu3qUXnU
— Haileyesus Getahun MD, MPH, PhD. (@hygetahun) September 17, 2020
Dr. Jacqueline Miller, Moderna's SVP, Infectious Diseases Development, is now presenting on the clinical development update of our COVID-19 vaccine candidate, mRNA-1273. https://t.co/WiMSqtIn7o pic.twitter.com/JtPc88kp0R
— Moderna (@moderna_tx) September 17, 2020
The U.S. is closing on 7M #Coronavirus cases and has > 200,000 deaths yet we still don’t have a National Strategy - @Worldometers Appreciate that yesterday at their Congressional hearing both @CDCDirector & @HHS_ASH said #WearAMask https://t.co/zfc2S8RRwq
— Carlos del Rio (@CarlosdelRio7) September 17, 2020
Science shows #forests can protect humans from infectious diseases and viruses. We need the @EU_Commission to help #StopDeforestation and protect our future.
— Rainforest Alliance (@RnfrstAlliance) September 17, 2020
TAKE ACTION #Together4Forests 👉 https://t.co/xcjU639Nqh pic.twitter.com/Er25Ae6lGl
"Antibiotic resistance is a grave international threat to life. While much attention has focussed around reducing use in clinical environments, we also need to urgently curb [resistance] in the natural environment." https://t.co/4zYap7fL24 #StopSuperbugs
— Antibiotic Action (@TheUrgentNeed) September 17, 2020
Several thousand people in Lanzhou, in northwest China, have tested positive for the bacterial disease #brucellosis, in an outbreak caused by a leak at a biopharmaceutical company last year.https://t.co/BgX5bvetRf #Brucella
— Microbes&Infection (@MicrobesInfect) September 17, 2020
New "Osterholm Update: COVID-19" podcast! @mtosterholm and @cvdall cover the need for US leadership, lingering #COVID19 symptoms in "long-haulers," the latest on various SARS-CoV-2 strains, and the importance of flu vaccination #fluvaxhttps://t.co/M4TN1Bhp3w pic.twitter.com/r4RgffywQs
— CIDRAP (@CIDRAP) September 17, 2020
“I start to sound like a broken record, but the one thing we know you can do is get a flu shot. It is the best thing we have in our toolbox for flu.”
— Yale University (@Yale) September 17, 2020
— Caitlin Hansen, @YaleMed prof. of Pediatric Infectious Diseases https://t.co/hZc3iafaXX
As in animals and plants, the genetic makeup of the fungus determines whether bacterial partners are perceived as mutualists or antagonists and what specific regulatory networks and response modules are initiated during each encounter. @mBioJournal https://t.co/l21QPpiPVR pic.twitter.com/wblVhPTec4
— ASM (@ASMicrobiology) September 17, 2020
Here is a case study (accepted to the Journal of the Pediatric Infectious Diseases Society) in which infected parents *tried* to infect their own children. And failed. https://t.co/TO6c3yPqVd
— Kristen Walsh 🩺🧸 (@DrKristenW) September 17, 2020
.@Forbes: "But when I get a chance to catch my breath, one worry that keeps coming back to my mind is the potential for this pandemic to amplify an already out of control, but resilient threat – the antimicrobial resistance epidemic." https://t.co/f6QVAygK0D #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) September 17, 2020
"It’s just ironic that the kind of intensive testing protocols that are being proposed are the things that we should’ve been doing months ago to protect our essential workers," says The director of UIHC Division of Infectious Diseases. https://t.co/NKv0VqDpKX @hellokatepayne
— Clay Masters (@Clay_Masters) September 17, 2020
“The ongoing need to educate the public about [the threat of #antibioticresistance] is becoming life and death,” @txst’s @RodneyRohde writes. https://t.co/HWDkwSeCr8 via @Forbes
— Save Antibiotics (@saveantibiotics) September 17, 2020
Subclinical tuberculosis disease - a review and analysis of prevalence surveys to inform definitions, burden, associations and screening methodology | Clinical Infectious Diseases | Oxford Academic https://t.co/nxNT61V2ny
— Tom (@TomScriba) September 17, 2020
Two great resources in Canada to help address asymptomatic bacteriuria:
— Brad Langford (@BRxAD) September 17, 2020
1. @PublicHealthON UTI Program https://t.co/dX8u45PcS8
2. @AMMICanada Symptom Free Pee, Let it Behttps://t.co/jgcp9TO4ed#ASPChat
New fluoroquinolone compounds with endo-nortropine derivatives at C-7 position show antibacterial activity against fluoroquinolone-resistant strains of Staphylococcus aureus. https://t.co/uj6wJ5j6VF
— AntibioticResistance (@AntibioticResis) September 17, 2020
Important (free) 4-part series coming up: "AMR in the Light of COVID-29. From hypothetical to reality: how COVID-19 foretells a world without #antibiotics." Part 1 is next Thursday and features great speakers! https://t.co/W2cop9Qecj #AntibioticResistance pic.twitter.com/Ez3pA3DIBF
— Battle Superbugs (@battlesuperbugs) September 17, 2020
The latest The antimicrobial stewardship Daily! https://t.co/1kxy2w0dB8 Thanks to @uabmedicine @CIDRAP_ASP @AMR_paper_bot #amr
— Abid Hussain (@MicrobLog_me_uk) September 17, 2020
Great commentary on "After #COVID19" from epi/ID legend Dr. Richard Wenzel; outlines what an ideal pandemic response would look like and looks ahead to the inevitable next pandemic.
— Mike Stevens (@Dr_Mike_Stevens) September 17, 2020
[I did have to look up "ineluctable"]@VCUHealth https://t.co/W4cOxYDjL1
Excellent webinar this evening, starting now hosted by Dr Btenda Khubeka @healthiq_za with expert guest @ProfGuyRichards. Join the session here 👉 https://t.co/WZ2V7dWB9T - #AntimicrobialStewardship #hcsmSA #ProtectAntibioticsZA pic.twitter.com/xEL6en2QE3
— Vanessa Carter (@_FaceSA) September 17, 2020
🤓🙏Very grateful to have the opportunity to contribute to this @Forbes article authored by the amazing @RodneyRohde
— Bug Pharmacist 💊🧫 Tim Gauthier (@IDstewardship) September 17, 2020
📲 https://t.co/U9xAtnHEgT #IDtwitter #TwitteRx pic.twitter.com/rNe0r9FosB
Nurses are crucial in the fight against #antimicrobial resistance and the adverse events that can occur when administering these drugs.https://t.co/98F0aFJz6g @DrRossRN @eamonsees @KatreenaMerrill @DiblasiLisa #antibioticstewardship #antibiotics #antibioticresistance
— OR Management News (@ORMgmtNews) September 17, 2020
Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection | Infectious Diseases | JAMA Ophthalmology | JAMA Network #COVID__19 🤓 https://t.co/QtZulKXhoN
— Farid Talih (@faridtalih) September 17, 2020
Staphylococcal enterotoxin B contributes to Staphylococcus aureus systemic infection | The Journal of Infectious Diseases | Oxford Academic https://t.co/6ddTWk0z35
— Wei Ping Teoh (@teohwp85) September 17, 2020
TODAY at 2 p.m. EDT! Join #COVID19 Research Registry Virtual Journal Club for a live discussion of a study that demonstrated the inhibitory effects of remdesivir in human lung cells in vitro by targeting the RNA-dependent RNA polymerase of SARS-CoV-2. https://t.co/Y3qUXIUEQg pic.twitter.com/t3jGsRXVX6
— ASM (@ASMicrobiology) September 17, 2020
Very cool infectious diseases / Immunology feature issue dedicated to...
— Yoni Maisel (@Primary_Immune) September 17, 2020
DIVERSITY
...well-worth checking out.https://t.co/k9sMKI21df #womeninSTEM #openscience #snrtg #iot #WomenInMedicine #blackinimmunoweek #immunology #scicomm pic.twitter.com/Zqnga3LKz5
The World Health Organisation’s
— Rob Hackett (@patientsafe3) September 17, 2020
Strategic and Technical Advisory Group for Infectious Hazards
now supports face mask use by the general public during the coronavirus pandemic: https://t.co/qifZFl48Mu#WhereIsYourMaskGladys? pic.twitter.com/sdh5OUDlKz
G0790 is a globomycin analog and inhibitor of the E. coli type II signal peptidase LspA. Unstable genomic amplifications of lspA can lead to modest yet biologically significant increases in LspA levels that confer a heteroresistance phenotype. @mBioJournal https://t.co/PliQPs8s4Q pic.twitter.com/1BUonKsVME
— ASM (@ASMicrobiology) September 17, 2020
A rise in new #coronavirus cases in Europe has been characterized as a “wake up call” by @WHO.
— Microbes&Infection (@MicrobesInfect) September 17, 2020
The number of new daily infections has reached record highs in some countries.
Targeted lockdowns & restrictions are returning across the continent.https://t.co/uSepL1DLTM #COVID19
Finally a potential upside to my presbyopia 👓
— Kirsten Bibbins-Domingo (@KBibbinsDomingo) September 17, 2020
Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection | Infectious Diseases | JAMA Ophthalmology | JAMA Network https://t.co/KY9ToE28OS
#COVID19 Pandemic Could Make #Antibiotic Resistance Worse 💪🏼👍 by @RodneyRohde says “Increase clinical competence through targeted training” I agree, @WHO was to implement its toolkit for LMIC this year to train more people https://t.co/1J38qYcmLq
— Debbie Goff (@idpharmd) September 17, 2020
STEWARDSHIP / RESISTANCE SCAN: Bacteriophages for UTI; Excessive antibiotic courseshttps://t.co/9xpxOzTBvi #AMR #AntibioticStewardship #phage
— CIDRAP (@CIDRAP) September 17, 2020
"It’s just ironic that the kind of intensive testing protocols that are being proposed are the things that we should’ve been doing months ago to protect our essential workers," says the director of UIHC Division of Infectious Diseases about the Big 10. >> https://t.co/mHqQXUWotX
— Iowa Public Radio (@IowaPublicRadio) September 17, 2020
Mr Mark, if you check the https://t.co/HYzoAMdKFv website under High consequence infectious diseases (HCID) you will see that covid19 was DOWNGRADED on 19th March to nothing more than the flu/a cold 🧐 hmmm
— Sharon Deegan (@TheSelfHelpHub) September 17, 2020
In Myxococcus xanthus the exopolysaccharide biosynthetic machine is a Wzx/Wzy-dependent pathway. Research using Wzx/Wzy pathway mutants published in @JBacteriology suggests that EPS or the EPS biosynthetic machinery is important for type IV pilus formation https://t.co/DVLEEXS6i9 pic.twitter.com/BW5V0Owluk
— ASM (@ASMicrobiology) September 17, 2020
Make flu vaccines easily accessible in disadvantaged communities, urges Dr. Leonard Mermel, FIDSA of @BrownMedicine.
— IDSA (@IDSAInfo) September 17, 2020
Our recent media briefing on influenza and COVID-19: https://t.co/ef7ILQeP7t pic.twitter.com/bykc1Vx4Pc
MEET OUR TEAM - DANILO BUONSENSO
— DFTB Skin Deep (@DFTBSkinDeep) September 17, 2020
Research Co-lead
"I am a paediatrician with main academic interests in Infectious Diseases, POCUS, and equality in healthcare. Surfing is my passion and inspiration."https://t.co/T1v7CA90AO#Medtwitter #paedsderm #globalhealth #foamed #foamped pic.twitter.com/lZ7LJNls1P
Atlas, a neuroradiologist who has no training in infectious diseases, public health or epidemiology, recently joined the White House coronavirus task force and appears to be favored by the president. https://t.co/xf1ZhojJ0m
— Lesley Russell Wolpe (@LRussellWolpe) September 17, 2020
Antibody responses in Covid-19 patients: What latest study reveals | @Health24com https://t.co/Wl6TU1Vllm pic.twitter.com/8adpAqIs0t
— News24 (@News24) September 17, 2020
In 2019, countries immunised 65 million children with Gavi support to protect each child against on average seven infectious diseases – that’s nearly half the children born in the world last year! #VaccinesWork https://t.co/gUvLkSOstY pic.twitter.com/vfnp4ubYHD
— Gavi, the Vaccine Alliance (@gavi) September 17, 2020
Microbiologists urge researchers to study the link between #socialdistancing and the #microbiome in new perspective in @ASMicrobiology's @mSphereJ https://t.co/9DnTy9TCKK pic.twitter.com/Mz702Nmfax
— ASM Newsroom (@ASMnewsroom) September 17, 2020
We're supporting the campaign for #InfectiousDiseases with @MediaplanetUK. Our very own President Maurizio Sanguinetti contributed an article on rapid antimicrobial resistance detection for early directed therapies against infectious diseases
— ESCMID (@ESCMID) September 17, 2020
Read online: https://t.co/U8dsgCINN5 pic.twitter.com/dh6ePKNQUO
Heavy exposure of children aged 9 to 12 years with SARS-CoV-2 did not lead to infection | Journal of the Pediatric Infectious Diseases Society | Oxford Academic https://t.co/XCf9cPVlPS
— Real_Dave_La_Torre 🍿 (@David_LaTorre) September 17, 2020
via @NYTimes The most meaningful analysis of the #Moderna #COVID19 #vaccine analysis of Phase 3 data appears more likely to happen in March or May 2021 rather than in December. https://t.co/LqJOLyAs7P
— Sanjaya Senanayake (@sanj971) September 17, 2020
Pathogenesis and immune response in #Brucella infection acquired by the respiratory routhttps://t.co/EUbuPB9PrA #brucellosis pic.twitter.com/jVoiU8SjnL
— Microbes&Infection (@MicrobesInfect) September 17, 2020
Inhibition of ribosome activity (ex: antibiotics) can result in a decrease in the amount of free RNA polymerase available for transcription, thus limiting the protein expression rate. @mSystemsJ https://t.co/XgppHf31NS pic.twitter.com/QJfrrnd3m8
— ASM (@ASMicrobiology) September 17, 2020
The situation update on #coronavirus has been updated on our website (17 September at 18:50).
— THL (@THLorg) September 17, 2020
🔹Samples tested: approx. 851,700
🔹Reported cases: 8,799
🔹Recovered: approx. 7,700
Read more 👇https://t.co/sdGQYvty4Z
I’m sure as the social media person, you don’t make policy but here is an article regarding medical conditions that prevent a person from wearing one. Hint:there aren’t any. https://t.co/Yi6P9WXD6x
— Jen Leone (@Jennnifa76) September 17, 2020
New resource in the #ReActToolbox:
— ReAct Action on ABR (@reactgroup) September 17, 2020
Manual from @Axfoundation with criteria aiming to ensure responsible use of #antibiotics in food animal sector. For food companies▶️ when interacting with suppliers of food products.
You find it in ENGAGE ASSESS table ⬇️https://t.co/fowlEriwIA pic.twitter.com/wihYJovsjL
#Antibiotics underpin modern medicine, but like any medication, antibiotics carry certain risks. That’s why the drugs should only be used appropriately and only when necessary. https://t.co/XQeqZljjSF #WorldPatientSafetyDay
— Save Antibiotics (@saveantibiotics) September 17, 2020
Updated preprint w. Davide Fumagalli and @erik_malmqvist online!#bioethics #healthpolicy #sustainability #antibioticresistance #antimicrobialresistance #AMR https://t.co/iW1kVZaBET
— Christian Munthe (@christianmunthe) September 17, 2020
Are #neutrophils important in #malaria? 🤔
— BSI Congress & Events (@bsicongress) September 17, 2020
Today at 14:00 BST, Dr Aubrey Cunnington will discuss recent evidence on their role in malaria & implications of these findings for other infectious diseases
🤩 You can still register 👉https://t.co/OPEzNLGS85 #BSIGroupWebinar pic.twitter.com/U5pbTYTRKD
#CaseStudy Male (22) presents with enlarged lymph nodes in his neck and complaints of fever & sore throat. Could this be due to #Measles, #Viral #hepatitis, #Malaria , #EBV or #CMV infection. Read more @ https://t.co/AksUuP456N pic.twitter.com/huQWZGmj7s
— Immunopaedia (@Immunopaedia) September 17, 2020
NIH studies conclude cloth masks cause more infectious diseases.https://t.co/iNJFfjai2M pic.twitter.com/3xYoHMeT0e
— Milo 🇺🇸 (@CoddeMilligan) September 17, 2020
121 Covid related deaths in children - CDC study. Per Dr. John Williams (Chief, Infectious Diseases, UPMC Children's Hospital of Pittsburgh), there is strong evidence of deep racial disparities in children (looking at Covid mortality).https://t.co/bqBuFH9o3F
— Srinivasan Suresh MD MBA (@SureshKidsDoc) September 17, 2020
Flu according to The WHO has a mortality rate of 0.1% at most https://t.co/mgUBfEeR7g but the rate for COVID is 0.65% - over 6 times more deadly and twice as infectious https://t.co/HXwqDgJ44l Happy to look at anything you've seen that suggests otherwise though.
— gniknori (@gniknori1) September 17, 2020
Professor of Infectious Diseases at Korea University Guro Hospital,
— H. Eric Loewe (@ericlo) September 17, 2020
Dr. Kim Woo-joo
Masks, etc.https://t.co/6kQmLi4kQ8
Published March 27, 2020
Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center | Infectious Diseases | JAMA Network Open | JAMA Network https://t.co/UfNV5mnId8
— Vineet Chopra (@vineet_chopra) September 17, 2020
Read the article by Dr. Luís M. T. Frija, Dr. Patrícia Rijo and et al. have assessed the antimicrobial activity of Saccharin–Tetrazolyl and –Thiadiazolyl Derivatives, in order to assess their potential to act as new drugs to treat infectious diseases.https://t.co/xB6wTxoro4 pic.twitter.com/RAUKYZlc44
— Pharmaceuticals MDPI (@Pharmaceut_MDPI) September 17, 2020
The Health 202: The CDC released a coronavirus vaccine plan. Trump is already contradicting it. - @washingtonpost surprised @pw_cunningham that Trump is contradicting science & evidence? https://t.co/BpbcCHHjw6
— Carlos del Rio (@CarlosdelRio7) September 17, 2020
It seemed a truth universally acknowledged that the human population had no pre-existing immunity to SARS-CoV-2, but is that actually the case#COVID19 : Do many people have pre-existing immunity? @bmj_latest https://t.co/uBUs2p1cJU
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 17, 2020
ON DEMAND WEBINAR: Learn how to assess the utility of #procalcitonin and other biomarkers for management of bacterial infection with focus on antimicrobial stewardship. @AACC #antibioticstewardship https://t.co/7dYRklRm4q pic.twitter.com/5fHZtyJkaZ
— Thermo Fisher (@thermofisher) September 17, 2020
Also, a "dirty" UA with WBC or bacteria is not diagnostic of a UTI. It may be suggestive of bacteriuria, but symptoms make the infection! #ASPChat
— Brandon Dionne (@BWDionne) September 17, 2020
As part of @MediaplanetUK's 2020 Infectious Diseases campaign, Dr. @hygetahun asserts the importance of antimicrobial access as a key part of UHC, noting how the COVID-19 pandemic has revealed close links between health and economic development (3/5) https://t.co/aHXmWgKCbM
— CIDRAP-ASP (@CIDRAP_ASP) September 17, 2020
NEWS: From Journal of the Pediatric Infectious Diseases Society: 12 Sep 2020:
— Jane Bailey (AcadiaU MtA)🇨🇦🇬🇧 (@peakpilot) September 17, 2020
Heavy exposure of children aged 9 to 12 years with SARS-CoV-2 did not lead to infection https://t.co/nfRlA33lzJ#COVID19 #Pediatrics #MedTwitter #MedTwitterPH #IDTwitter @CBCNews @CTVNews #schools
The Health Commission of Lanzhou, the capital city of Gansu province, confirmed that 3,245 people had contracted the disease brucellosis, in an outbreak caused by a leak at a biopharmaceutical company last year. 😳https://t.co/Y52k4gamHw
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 17, 2020
CDC director says coronavirus vaccines won’t be widely available till the middle of next year https://t.co/TZ5yRytYdG
— Andrew Pavia (@AndrewPaviaMD) September 17, 2020
"Previously, in the world of infectious diseases, it has been accepted that a ‘case’ represents someone with symptoms, usually severe symptoms, usually severe enough to be admitted to hospital."https://t.co/oU6UaeHPZm
— Shawn (@Lagavulindrinkr) September 17, 2020
In a new @NewsfromScience article, Laura Nyblade shares how stigma can perpetuate the spread of infectious diseases like #HIV and now #COVID19: https://t.co/y7Ef2p1h4w
— RTI International (@RTI_Intl) September 17, 2020
NEWS SCAN: High viral load and #COVID19 death; Eastern equine encephalitis in Indiana; #Avianflu in Kazakhstanhttps://t.co/42R69MIjZG
— CIDRAP (@CIDRAP) September 17, 2020
WP3 is working on a paper related to the use of heterogeneity in health-economic evaluations of infectious disease prevention. A publication is planned for later this year. Read more at https://t.co/escrk4Vl4Z #vaccines #elderly #elderlylivesmatter #heterogeneity #publichealth
— VITAL (@VITAL_Europe) September 17, 2020
"Antibiotics are the weakest link in our health and economic security and their discovery and access needs government investment and partnership."
— Richard H. Ebright (@R_H_Ebright) September 17, 2020
Antibiotics must be accessible to citizens who need themhttps://t.co/lqTY6eBPu0
For Article summary translation in Georgian and German see https://t.co/JJzgEF9Iau pic.twitter.com/RoKHhpM825
— The Lancet Infectious Diseases (@TheLancetInfDis) September 17, 2020
If the WH tries to cut corners on a coronavirus vaccine, “it would be blown out of the water publicly.” https://t.co/6yOOuTAJvL
— Tim Lahey (@TimLaheyMD) September 17, 2020
Our #faculty Prof. Anjana Saxena's study @BklynCollege411 "uncovers Piezo1 as a targetable immune checkpoint that drives immunosuppressive myelopoiesis in #cancer and #infectiousdiseases" Here's her paper_ #CancerResearch #ScienceTwitter https://t.co/dhY1kZZKGS
— GC CUNY Biology (@GradCenterBio) September 17, 2020
The concept of #AntimicrobialStewardship is perhaps more important now than ever before. But what is #AMS? How does it help #StopSuperbugs? Catch-up on episode 3 of ‘The Steward’ where we discuss this and more. Want to feature in future episodes? DM us! https://t.co/89X0D9ZdKt pic.twitter.com/gFx1tS64jW
— MSD (@MSDintheUK) September 17, 2020
Why should hospitals implement #antimicrobialstewardship programs?@ErinMcCreary shared her thoughts in our most recent webinar: https://t.co/d5trvd0KVd pic.twitter.com/l2Z6TBHqQ3
— IDConnect (@IDConnect1) September 17, 2020
Another must read but shocking piece of reporting. If it looks like something CDC wouldn't have done, it probably wasn't. Look to politicians at the WH. C.D.C. Testing Guidance Was Published Against Scientists’ Objections https://t.co/7wEluPJhcd
— Andrew Pavia (@AndrewPaviaMD) September 17, 2020
CDC and WHO estimate that COVID-19 has a fatality rate of ~ 0.6%. ~ 6X that of a typical flu season. But what about the Marburg virus, for which the Angola strain has a reported 90% lethality? https://t.co/wWKOgbNDii #flu #marburg #COVID-19 #infectiousdiseases $GOVX pic.twitter.com/jnULrnEDcJ
— GeoVax, Inc. (@Geovax_News) September 17, 2020
Want ASM Member exclusive programs for half the price? Sign up by 9/30 & get instant access to education webinars, #ASMMicrobeOnline content, monthly virtual journal clubs and more, from now until end of 2020. 2020 ASM membership expires on 12/31/2020. https://t.co/BFNTdLXcD4 pic.twitter.com/fkAr1k52wW
— ASM (@ASMicrobiology) September 17, 2020
#PISA2020 Symposia: Host Protection and Responses to Infectious Diseases @BU_Tweets @NIAIDNews https://t.co/UMt7z5bqfx Register: https://t.co/TDEDRjSlPL @AcademicChatter @sciencebot_gms Trainees get #FREE registration! #phdchat pic.twitter.com/hXGDwxzKYE
— ASIP (@ASIPath) September 17, 2020
.@ImmunoPrecise to tap @ZymeworksInc #Azymetric & #EFECT platforms for #COVID19 #immunotherapy
— DDNews Online (@DDNewsOnline) September 17, 2020
Transform existing #SARSCoV2 #neutralizing #antibodies into #bispecific & multispecific formatshttps://t.co/Ihcs2x3kRe#InfectiousDiseases #biologics pic.twitter.com/y0qsEpcKXr
Association of Routine Infant Vaccinations With Antibody Levels Among Preterm Infants | Infectious Diseases | JAMA | https://t.co/s9ysqBMaLU via @JAMA_current
— Josep Vidal-Alaball MD, PhD, MPH🎗 (@jvalaball) September 17, 2020
ICYMI: @IDSAInfo issued new guidance for the treatment of 3 common #antibiotic-resistant pathogens. https://t.co/vzOnAHXQGT
— Save Antibiotics (@saveantibiotics) September 17, 2020
Inhibition of antigen presentation by #Brucella:
— Microbes&Infection (@MicrobesInfect) September 17, 2020
Many more than many wayshttps://t.co/FjjzyzC9Pp #brucellosis pic.twitter.com/PWMQG1pXVc
Not to be a pedant, but we are living in an unprecedented era for fungal diseases of multiple ecosystems, involving animals, plants, humans and environment. As you contemplate wild fires and climate change, just another thing to think about. https://t.co/7RIuiejp3o https://t.co/jsAPF002tN
— Neil Clancy (@ClancyNeil) September 17, 2020
Plus linked Comment--Bacteriophages: it's a medicine, Jim, but not as we know it https://t.co/sCXB27CiU3
— The Lancet Infectious Diseases (@TheLancetInfDis) September 17, 2020
The biopharmaceutical industry is the 3rd largest funder for R&D specifically targeting emerging infectious diseases. Read the new #GFinder report on the “Landscape of Emerging Infectious Disease R&D: Preventing the next pandemic” @PCuresResearch https://t.co/jcLW0BvilT
— IFPMA (@IFPMA) September 17, 2020
Universal Masking for HCW Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers | Infectious Diseases | JAMA | JAMA Network https://t.co/AZCqz2iQP6
— Ghina Ghazeeri (@GGhazeeri) September 17, 2020
Created by Cameron Forbes. Last updated September 19, 2020 at 05:08 EST.